E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

Investor Relations

DGX (Common Stock)
ExchangeNYSE (US Dollar)
Price$59.65
Change (%) Stock is Up 0.84 (1.43%)
Intraday High$59.65
Intraday Low$58.40
Volume1,547,683
Data as of 10/20/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Headlines More >
TitleDate
Quest Diagnostics To Release Third Quarter 2014 Financial Results On October 23
MADISON, N.J., Oct. 7, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2014 results on Thursday, October 23, 2014, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can also be accessed in listen-only mode by dialing 415-228-4961, passcode 3214469. The company suggests pa... 
10/07/14
Quest Diagnostics Unveils New State-of-the-Art Clinical Laboratory in Marlborough, Massachusetts
Congresswoman Niki Tsongas, Representative Danielle Gregoire and Marlborough Mayor Arthur Vigeant join community event to open 200,000 square-foot "lab of the future" designed to deliver innovative, efficient diagnostic information services to New England Medical experts from UMass Memorial Medical Group and the University of Massachusetts to provide scientific leadership for testing onsite MARLBOROUGH, Mass., Oct. 2, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leadin... 
10/02/14
Quest Diagnostics Names Mayo Clinic Executive Franklin R. Cockerill, M.D., Vice President and Chief Laboratory Officer
Former president and CEO of Mayo Medical Laboratories and chair of lab medicine and pathology for Mayo Clinic to oversee Quest's clinical testing operations MADISON, N.J., Oct. 1, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Franklin R. Cockerill, III, M.D., has joined the company as vice president and chief laboratory officer, effective October 1, 2014. Dr. Cockerill w... 
10/01/14
Quest Diagnostics To Host Investor Day On November 5, 2014
MADISON, N.J., Oct. 1, 2014 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the  world's leading provider of diagnostic testing, information and services, will host Investor Day for institutional investors and financial analysts in New York City on Wednesday, November 5, 2014 at The Hudson Theatre at the Millennium Broadway, 145 West 44th Street, New York, NY.  During the event, Quest Diagnostics executives will discuss the company's strategy, performance and plans to drive s... 
10/01/14
Upcoming EventsMore >
DateTitle
10/23/14
Q3 2014 Quest Diagnostics Earnings Release
10/23/14
Q3 2014 Quest Diagnostics Earnings Conference Call
11/05/14
Quest Diagnostics Investor Day
Contact Us:
Dan Haemmerle
Executive Director Investor Relations
973-520-2900
Investor@QuestDiagnostics.com

Company Calendar
October 2014?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-3-2-11234
567891011
12131415161718
1920212223
10/23/14
Q3 2014 Quest Diagnostics Earnings Release
8:30 a.m. ET
Q3 2014 Quest Diagnostics Earnings Conference Call
2425
26272829303151

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.